Pharmaceuticals and innovation. Less buck for the bang. Are drug patents worth it?

- The Economist

Politicians are attacking IP protection, but shareholders are Big Pharma’s bigger headache | Business


View Original...


Visibility: Public (all visitors)





Related Chunks (collections)

This ARTICLE is used in 2 chunks
Saved by Course Chunks